Keding Enterprises Establishes Tokyo Branch Office to Strengthen Service Network in Japan and Launches Global Distributor Program

TAIPEI, May 20, 2025 /PRNewswire/ -- As the demand for high-quality and sustainable building materials continues to rise in Japan, Keding Enterprises is actively expanding its international presence. Recognizing the growing demand in the Japanese interior design industry for eco-friendly, durable, and aesthetically pleasing surface materials, the company sees significant market potential ahead. According to Transparency Market Research, the decorative laminate market in Japan is projected to grow further, reaching JPY 43 billion by 2025—highlighting promising business opportunities.

In March 2025, KEDING participated in the Architecture + Construction Materials 2025 exhibition held in Tokyo, showcasing its signature products including KD ECO⺠Laminates and attractive partnership opportunities for distributors. The event drew inquiries from over 100 architects, interior designers, and building material dealers, who praised the product's quality, ease of installation, and sustainability.

To provide more timely and professional local support and to meet the growing number of customers in Japan, KEDING officially announced the establishment of its Tokyo branch office in 2025. This office is operated by a local professional team and is accompanied by a newly established warehousing and logistics system to improve supply efficiency and service quality—creating a robust model for international collaboration. This move not only strengthens trust with Japanese customers but also reflects KEDING's commitment to deeply cultivating the local market, backed by 23 years of industry experience.

Currently, KD ECO⺠Laminates from KEDING are widely used across various projects in Japan, including high-end resort hotels and large public facilities in Tokyo, Okinawa, and Hokkaido.

KEDING's Eco-Friendly Laminates Stand Out — Seeking Distributor in Japan

Compared to conventional surface materials, KD ECO⺠Laminates offer numerous technical and design advantages, such as seamless edge appearance, flexible bendability, and excellent installation efficiency—providing greater design freedom. With over 288 color options, these products are ideal for high-end residences, boutique hotels, commercial spaces, and more, and are highly favored by designers worldwide.

To further expand in the Japanese market, KEDING has launched a local distributor and franchise recruitment plan, actively seeking partnerships with design firms, building material agencies, interior designers, and building material distributors. For its partners, KEDING offers multifaceted support including client referrals, training programs, and a localized supply system, with the goal of promoting high-quality and sustainable interior material solutions together.

Those interested in becoming a distributor partner or learning more about KEDING's products are welcome to contact us through the information below:

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Keding Enterprises Establishes Tokyo Branch Office to Strengthen Service Network in Japan and Launches Global Distributor Program

Keding Enterprises Establishes Tokyo Branch Office to Strengthen Service Network in Japan and Launches Global Distributor Program

Keding Enterprises Establishes Tokyo Branch Office to Strengthen Service Network in Japan and Launches Global Distributor Program

Keding Enterprises Establishes Tokyo Branch Office to Strengthen Service Network in Japan and Launches Global Distributor Program

T. Rowe Price Investment Management, Inc. and Braidwell LP participate as new investors

Stephen Williams, MD, Ph.D. joins as Chief Scientific Officer

Rebecca Chambers and Frank Witney, Ph.D. appointed to Board of Directors

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the early detection of disease, announced the close of an oversubscribed convertible notes financing, bringing in more than $50 million of new capital. Accounts advised by T. Rowe Price Investment Management, Inc. and Braidwell LP joined the financing as new investors. Existing investors, including Illumina Ventures and Sands Capital, also participated. The financing will support the continued commercial advancement of Alamar's precision proteomics platform.

"We deeply appreciate the continued support from our existing investors and are excited to welcome our new partners," said Dr. Yuling Luo, founder, chairman, and chief executive officer of Alamar. "Their confidence in our vision and strategy underscores the transformative potential of our work. This investment will enable us to accelerate innovation and continue to expand the reach of our platform, unlocking the full value of precision medicine and early disease detection."

Leadership and Board Expansion
Alamar also announced key additions to its executive leadership team and board of directors to support the company's continued growth and commitment to operational excellence.

 

 

To further strengthen its scientific leadership, Alamar welcomes Dr. Stephen Williams as Chief Scientific Officer. Steve brings more than three decades of experience in precision medicine and biomarker innovation. He most recently served as Chief Medical Officer at Standard BioTools and SomaLogic, and previously spent 18 years at Pfizer in senior leadership roles. A recognized leader in the scientific community, he has served on the NIH National Advisory Council for Biomedical Imaging and Bioengineering, helped launch the Alzheimer's Disease Neuroimaging Initiative, and co-founded the FDA-FNIH-PhRMA Biomarker Consortium.

Alamar has also appointed Rebecca Chambers and Dr. Frank Witney as directors to its board. Rebecca, Chief Financial Officer at Veracyte, brings deep financial and healthcare leadership experience from her current role as well as previous positions at Outset Medical, Illumina, Myriad Genetics and Life Technologies. Frank, an operating partner at Ampersand Capital Partners, adds over three decades of life sciences leadership experience, including serving as President and CEO of Affymetrix and Dionex Corporation, and currently sits on the boards of Revvity, Cerus Corporation, Standard BioTools, and several private companies.

"I am thrilled to welcome Steve to our leadership team, and Rebecca and Frank to our board of directors," said Dr. Yuling Luo. "Their deep expertise and diverse perspectives will be invaluable as we accelerate our mission to unleash the power of our Precision Proteomics platform, to enable broad impacts across health and disease. This is an exciting moment for Alamar, and we look forward to the impact their leadership will have on driving innovation and growth."

About Alamar Biosciences, Inc. 
Alamar Biosciences is a privately held life sciences company dedicated to powering precision proteomics to enable the earliest detection of disease. Leveraging its proprietary NULISA™ technology and the ARGO™ HT System, Alamar's platform is designed to deliver ultra-high sensitivity and addresses key limitations of existing technologies to deliver precision proteomics. For more information, please visit alamarbio.com. 

 

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team